RC

Roshan Champalal Jain

Active Director Partner DIN 00486211
DIN 00486211 First appointment Feb 2006 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 1 historical roles
Total affiliations 10 Since Feb 2006
Shareholding value •••• Premium profile

About Roshan Champalal Jain

Data last updated:

Roshan Champalal Jain has 20 years in corporate governance. Holds Partner and Director roles. Currently with 9 companies, including Anutej Vastunirman Llp and Arihant Chemist Llp. Formerly with 1 company, such as Rajchandra Trading Company Pvt Ltd. Engaged in General Business. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹391 Cr; the largest is Zyphar's Pharmaceutics Private Limited at ₹222 Cr (FY 2025).

DIN 00486211
Primary Designation Partner
First Appointment 17 Feb 2006
Oldest Company Age 20 yrs
Largest company Zyphar's Pharmaceutics Private Limited · ₹222 Cr (FY 2025)
Combined revenue ₹391 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Feb 20062006₹222 Cr (FY 2025)Active
Partner28 Jan 20192018₹125 Cr (FY 2021)Active
Director06 Nov 20122012₹24.46 Cr (FY 2025)Active
Director17 May 20102007₹18.47 Cr (FY 2025)Active
Xion Pharmaceuticals Private Limited U24231PN2007PTC130248
Director04 Jun 20072007₹1.76 Cr (FY 2025)Active
Director01 Jul 20082008₹11,000 (FY 2023)Active
Designated Partner12 Nov 20212021–Active
Partner01 Jan 20152014–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rajchandra Trading Company Pvt Ltd U51909PN2003PTC017982
Director29 Jul 20062003₹1.19 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Anutej Vastunirman Llp
Arihant Chemist Llp
Zyphar's Pharmaceutics Private Limited
Xion Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Roshan Champalal Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roshan Champalal Jain

Roshan Champalal Jain has 20 years in corporate governance. Holds Partner and Director roles. Currently with 9 companies, including Anutej Vastunirman Llp and Arihant Chemist Llp. Formerly with 1 company, such as Rajchandra Trading Company Pvt Ltd. Engaged in General Business. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹391 Cr; the largest is Zyphar's Pharmaceutics Private Limited at ₹222 Cr (FY 2025).

Roshan Champalal Jain is associated with 9 companies as Partner and Director, including Zyphar's Pharmaceutics Private Limited (₹222 Cr), Arihant Chemist Llp (₹125 Cr), Skin Aesthetics International Private Limited (₹24.46 Cr).

Roshan Champalal Jain has expertise in General Business.

Roshan Champalal Jain has 20 years in corporate governance.

By reported revenue, the largest current company of Roshan Champalal Jain is Zyphar's Pharmaceutics Private Limited, with revenue of ₹222 Cr (FY 2025).

The 6 current companies of Roshan Champalal Jain that report revenue have a combined latest revenue of ₹391 Cr.

Roshan Champalal Jain currently holds positions at 9 companies; the 5 largest by reported revenue are Zyphar's Pharmaceutics Private Limited (₹222 Cr), Arihant Chemist Llp (₹125 Cr), Skin Aesthetics International Private Limited (₹24.46 Cr), Sinsan Pharmaceuticals Private Limited (₹18.47 Cr), Xion Pharmaceuticals Private Limited (₹1.76 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available